Resultado da Busca
15 de mai. de 2024 · Press release - DataM Intelligence Market Research - Immuno-Oncology (IO)-Thematic Intelligence Market 2024 Projections, Trends and Forecast 2024 - DataM Intelligence - published on openPR.com
24 de mai. de 2024 · Figure 5. Estimated timeline of emerging therapeutic targets in the field of immuno-oncology based on NLP analysis of >350K publications from the CAS Content Collection for the period 2000−2022. CDK4/631) have doubled, while those for nectin-4,29 α-enolase 1 (ENO1),30 and hematopoietic progenitor kinase (HPK)31 have nearly tripled over the ...
17 de mai. de 2024 · Published May 17, 2024. The global Immuno Oncology Assays Market boasts a total value of $4.4 billion in 2021 and is projected to register a growth rate of 12.5% to reach a value of $7.9 billion ...
29 de mai. de 2024 · 2654 Background: Immuno-oncology (IO) therapy can cause cytokine release syndrome (CRS) events, which are a constellation of co-occurring signs and symptoms that usually present within 24–48 hours after treatment. There is no clinical consensus on the specific sign and symptom profile for IO-induced CRS. The objectives of this study were to better understand the experiences of patients with ...
16 de mai. de 2024 · Reserve your spot now! DIMA invites you to attend the Cancer Research & Immuno-Oncology Week Virtual Event Series, an online-only virtual event occurring on October 3 – 5, 2023. The 11th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series will provide the opportunity to explore global developments and advancements ...
28 de mai. de 2024 · Immuno-oncology, also known as cancer immunotherapy, is a rapidly growing field that studies the ways in which the body’s own immune system can fight cancer. It has the potential to uncover ways to enable immunogenicity of all types of cancer and facilitate long-lasting, protective immunity against future recurrence.
20 de mai. de 2024 · KEY MARKET INSIGHTS. The global immunology market size was valued at USD 97.58 billion in 2023. The market is projected to grow from USD 103.18 billion in 2024 to USD 257.39 billion by 2032, exhibiting a CAGR of 12.1% during the forecast period. Immunology agents or drugs modify the immune response by suppressing or enhancing the immune system.
